• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对患有浸润性乳腺癌的黑人女性群体中的T细胞亚群进行定量分析。

Quantitative analysis of T cell subsets in a population of Black women with invasive breast cancer.

作者信息

Omilian Angela R, Mendicino Lucas, George Anthony, Darabnoushtehrani Tina, Ondracek Rochelle Payne, Bshara Wiam, Hong Chi-Chen, Qin Bo, Bandera Elisa V, Khoury Thaer, Cannioto Rikki, Yao Song, Ambrosone Christine B

机构信息

Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.

Department of Pathology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.

出版信息

NPJ Breast Cancer. 2025 Jul 1;11(1):64. doi: 10.1038/s41523-025-00780-5.

DOI:10.1038/s41523-025-00780-5
PMID:40593864
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12218130/
Abstract

We compared T cell subpopulations in primary invasive breast tumors from Black and White women and investigated breast cancer subtype-specific associations of T cell abundance with survival in Black women. Multispectral immune staining was used to quantify helper, cytotoxic, and regulatory T cells in the tumor and stromal compartments of breast tissues. In fully adjusted models, breast tumors from Black women were significantly more likely than those from White women to have a higher abundance of cytotoxic T cells (IRR, 2.41; 95% CI, 1.43-4.05) and helper T cells (IRR, 1.80; 95% CI, 1.06-3.06), and these differences were more pronounced in the tumor than the stromal compartment. Among Black women, higher levels of T cells were associated with improved survival in women with triple-negative breast cancer, whereas a trend of poorer survival was observed in women with HER2-positive tumors. This study contributes to an accumulating body of evidence that the tumor-immune landscape differs between Black and White women.

摘要

我们比较了黑人和白人女性原发性浸润性乳腺癌中的T细胞亚群,并研究了黑人女性中T细胞丰度与生存的乳腺癌亚型特异性关联。采用多光谱免疫染色法对乳腺组织肿瘤和基质区室中的辅助性T细胞、细胞毒性T细胞和调节性T细胞进行定量。在完全调整模型中,黑人女性的乳腺肿瘤比白人女性的肿瘤更有可能具有更高丰度的细胞毒性T细胞(发病率比值比[IRR],2.41;95%置信区间[CI],1.43 - 4.05)和辅助性T细胞(IRR,1.80;95% CI,1.06 - 3.06),且这些差异在肿瘤区室比基质区室更明显。在黑人女性中,T细胞水平较高与三阴性乳腺癌女性的生存改善相关,而在HER2阳性肿瘤女性中观察到生存较差的趋势。这项研究为越来越多的证据提供了补充,即黑人和白人女性的肿瘤免疫格局不同。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ab7/12218130/669258687da8/41523_2025_780_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ab7/12218130/fdfa698e51ab/41523_2025_780_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ab7/12218130/f3e0a422b528/41523_2025_780_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ab7/12218130/669258687da8/41523_2025_780_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ab7/12218130/fdfa698e51ab/41523_2025_780_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ab7/12218130/f3e0a422b528/41523_2025_780_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ab7/12218130/669258687da8/41523_2025_780_Fig3_HTML.jpg

相似文献

1
Quantitative analysis of T cell subsets in a population of Black women with invasive breast cancer.对患有浸润性乳腺癌的黑人女性群体中的T细胞亚群进行定量分析。
NPJ Breast Cancer. 2025 Jul 1;11(1):64. doi: 10.1038/s41523-025-00780-5.
2
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
3
Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk.乳腺 X 线摄影联合乳腺超声与乳腺 X 线摄影用于一般风险女性乳腺癌筛查。
Cochrane Database Syst Rev. 2023 Mar 31;3(3):CD009632. doi: 10.1002/14651858.CD009632.pub3.
4
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
5
Platinum-containing regimens for metastatic breast cancer.转移性乳腺癌的含铂方案。
Cochrane Database Syst Rev. 2017 Jun 23;6(6):CD003374. doi: 10.1002/14651858.CD003374.pub4.
6
Short-term and long-term effects of tibolone in postmenopausal women.替勃龙对绝经后女性的短期和长期影响。
Cochrane Database Syst Rev. 2016 Oct 12;10(10):CD008536. doi: 10.1002/14651858.CD008536.pub3.
7
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.暴力死亡监测——2022年全国暴力死亡报告系统,50个州、哥伦比亚特区和波多黎各
MMWR Surveill Summ. 2025 Jun 12;74(5):1-42. doi: 10.15585/mmwr.ss7405a1.
8
Prophylactic mastectomy for the prevention of breast cancer.预防性乳房切除术用于预防乳腺癌。
Cochrane Database Syst Rev. 2004 Oct 18(4):CD002748. doi: 10.1002/14651858.CD002748.pub2.
9
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
10
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.

本文引用的文献

1
Spatial transcriptomics reveals substantial heterogeneity in triple-negative breast cancer with potential clinical implications.空间转录组学揭示了三阴性乳腺癌的显著异质性,具有潜在的临床意义。
Nat Commun. 2024 Nov 26;15(1):10232. doi: 10.1038/s41467-024-54145-w.
2
Associations of Immune Checkpoint Predictive Biomarkers (MHC-I and MHC-II) with Clinical and Molecular Features in a Diverse Breast Cancer Cohort.免疫检查点预测生物标志物(MHC-I 和 MHC-II)与多样化乳腺癌队列中临床和分子特征的关联。
Clin Cancer Res. 2024 Sep 13;30(18):4077-4081. doi: 10.1158/1078-0432.CCR-24-1286.
3
CD163 macrophages in the triple-negative breast tumor microenvironment are associated with improved survival in the Women's Circle of Health Study and the Women's Circle of Health Follow-Up Study.
三阴性乳腺癌肿瘤微环境中的 CD163 巨噬细胞与妇女健康研究和妇女健康随访研究中的生存改善相关。
Breast Cancer Res. 2024 May 8;26(1):75. doi: 10.1186/s13058-024-01831-8.
4
Tumor-Associated Lymphocytes and Breast Cancer Survival in Black and White Women.肿瘤相关淋巴细胞与黑人和白人女性乳腺癌的生存率
JAMA Surg. 2024 Jun 1;159(6):712-714. doi: 10.1001/jamasurg.2023.8024.
5
Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer.不同空间免疫微环境与三阴性乳腺癌的预后独立相关。
Nat Commun. 2023 Apr 18;14(1):2215. doi: 10.1038/s41467-023-37806-0.
6
Regional Variation in the Tumor Microenvironment, Immune Escape and Prognostic Factors in Breast Cancer in Sub-Saharan Africa.撒哈拉以南非洲地区乳腺癌的肿瘤微环境、免疫逃逸和预后因素的区域差异。
Cancer Immunol Res. 2023 Jun 2;11(6):720-731. doi: 10.1158/2326-6066.CIR-22-0795.
7
African Ancestry-Associated Gene Expression Profiles in Triple-Negative Breast Cancer Underlie Altered Tumor Biology and Clinical Outcome in Women of African Descent.非洲裔美国人相关基因表达谱在三阴性乳腺癌中改变肿瘤生物学和临床结局,并与非洲裔女性相关。
Cancer Discov. 2022 Nov 2;12(11):2530-2551. doi: 10.1158/2159-8290.CD-22-0138.
8
Tumor immune microenvironment of self-identified African American and non-African American triple negative breast cancer.自我认定的非裔美国人和非非裔美国人三阴性乳腺癌的肿瘤免疫微环境
NPJ Breast Cancer. 2022 Jul 22;8(1):88. doi: 10.1038/s41523-022-00449-3.
9
The Landscape of Immune Microenvironments in Racially Diverse Breast Cancer Patients.不同种族乳腺癌患者的免疫微环境全景图。
Cancer Epidemiol Biomarkers Prev. 2022 Jul 1;31(7):1341-1350. doi: 10.1158/1055-9965.EPI-21-1312.
10
Tumor immune cell clustering and its association with survival in African American women with ovarian cancer.肿瘤免疫细胞聚类及其与非裔美国卵巢癌女性生存的关联。
PLoS Comput Biol. 2022 Mar 2;18(3):e1009900. doi: 10.1371/journal.pcbi.1009900. eCollection 2022 Mar.